Golimumab (simponi) for inflammatory arthritis

MeSH terms

• Anti-Inflammatory Agents / administration & dosage
• Anti-Inflammatory Agents / adverse effects
• Anti-Inflammatory Agents / pharmacokinetics
• Anti-Inflammatory Agents / therapeutic use*
• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal / pharmacokinetics
• Antibodies, Monoclonal / therapeutic use*
• Arthritis, Psoriatic / drug therapy*
• Arthritis, Psoriatic / immunology
• Arthritis, Rheumatoid / drug therapy*
• Arthritis, Rheumatoid / immunology
• Chemistry, Pharmaceutical
• Drug Therapy, Combination
• Humans
• Immunosuppressive Agents / therapeutic use
• Injections, Subcutaneous
• Methotrexate / therapeutic use
• Spondylitis, Ankylosing / drug therapy*
• Spondylitis, Ankylosing / immunology
• Treatment Outcome
• Tumor Necrosis Factor-alpha / antagonists & inhibitors*